SecBot SecBot
PRESS-RELEASE ·Filed Aug 11, 2026

AVR

Anteris Technologies Global Corp.
BEARISH
Impact 6/10
Horizondays Processed2mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▼ Bearish

The EPS miss is significant for a pre-revenue company where cash burn is the key metric; watch for the full 10-Q filing to assess operating expense trends and cash runway. The 88% analyst bullish consensus and recent insider selling create a risk of downgrades or price target cuts. Monitor for any pipeline updates or financing announcements in the coming weeks.

DirectionBearish
Confidencehigh
Horizondays
Latest settled — T+20d
AVR ▼ -6.43% at T+20d
SHORT call ✓ call won +6.43% · α vs SPY +4.53% · entry $8.87 → $8.30
Next anchor: T+60d in 8d
Latest observation: T+51 +39.84% FF3 residual α
Entry = T+0 close
Aug 11, 2026
via day close
T+1d
+0.68%
call -0.68% · α +0.02%
$8.93
settled 3mo ago
T+5d
+10.82%
call -10.82% · α -11.27%
$9.83
settled 2mo ago
T+20d
-6.43%
call +6.43% · α +4.53%
$8.30
settled 7w ago
T+60d
Pending
in 8d

Price Chart

Loading chart...

Executive Summary

Anteris Technologies reported Q2 2026 EPS of $-0.28, a 35.5% miss vs the $-0.21 consensus estimate, with revenue of $2.1M in line with expectations. The miss is notable for a pre-revenue clinical-stage company where EPS surprises on a small base are mechanical, but the magnitude of the miss signals higher-than-expected operating expenses or slower pipeline progress.

Key Financial Metrics

EPS
−$0.28
est −$0.21 · -33.3%
Revenue
$2.1M
est $2.1M · 0.0%
Rating
miss

Key Facts

  • EPS of $-0.28 missed consensus of $-0.21 by 35.5%
  • Revenue of $2.1M matched consensus
  • Q2 2026 period ended June 30, 2026
  • 88% of analysts rate the stock Buy or Strong Buy
  • Recent insider selling: 10 sells totaling $19.6M in the last 30 days

Financial Impact

EPS miss of $0.07 per share vs consensus

eps

Risk Factors

  • EPS miss may trigger analyst downgrades given high bullish consensus
  • Insider selling of $19.6M in the last 30 days suggests management caution
  • Pre-revenue stage means cash burn rate is critical; higher expenses could accelerate dilution risk

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3343309
15 reports for AVR
Performance horizon
50% Hit rate @ T+20 3 of 6 directional calls Went positive at some point 5 of 8 best @ T+20▲ +20.28%Feb 27, 2026
Filters
Rows
Reports for AVR — sortable, filterable
TypeNow
Oct 6, 2026
21d ago
Insider Buy
BULLISH ★ 6/10
$7.05awaiting T+20—$6.03 (−14.40%)
Oct 1, 2026
25d ago
Insider Buy
BULLISH ★ 5/10
$7.71awaiting T+20—$6.03 (−21.73%)
Sep 23, 2026
4w ago
8-K
NEUTRAL ★ 2/10
$7.62 $6.01▼ −21.13%▼ −21.82%$6.03 (−20.80%)
Sep 17, 2026
5w ago
8-K
NEUTRAL ★ 3/10
$8.16 $6.05▼ −25.86%▼ −26.06%$6.03 (−26.04%)
Sep 16, 2026
5w ago
3
NEUTRAL ★ 2/10
$8.37 $6.26▼ −25.21%▼ −27.27%$6.03 (−27.90%)
Sep 8, 2026
7w ago
8-K
NEUTRAL ★ 3/10
$8.62 $7.05▼ −18.21%▼ −20.18%$6.03 (−29.99%)
Aug 14, 2026
10w ago
Institutional Cluster
BULLISH ★ 6/10
$9.42 $8.72▼ −7.43%▼ −5.91%$6.03 (−35.93%)
Aug 11, 2026
10w ago
Press Release
BEARISH ★ 6/10
$8.87 $8.30▲ +6.43%▲ +4.53%$6.03 (+31.96%)
Jul 31, 2026
12w ago
8-K
NEUTRAL ★ 4/10
$7.84 $8.74▲ +11.48%▲ +8.49%$6.03 (−23.02%)
Jul 28, 2026
13w ago
Insider Buy
BULLISH ★ 8/10
$8.17 $8.89▲ +8.81%▲ +5.43%$6.03 (−26.13%)
Showing 10 of 15

US Market Status

Market Open — Closes in 1h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 11, 2026